Horowitz: The censorship of ivermectin is the biggest story of COVID

Last week, Manitoba Premier Brian Pallister launched a $1 million grant to convince "hesitant" communities to get themselves vaccinated with one of the experimental shots on the market. But if people are hesitant about an experimental gene therapy that has already racked up a record number of serious adverse events on the CDC's Vaccine Adverse Event Reporting System (VAERS), why not spend the money persuading people to get ivermectin, a safe and effective early and prophylactic COVID treatment that has been approved by the FDA and the WHO for other uses for years?

In a recent video clip from one of his forums, Pallister was asked by a caller about another kind of hesitancy – not hesitancy to vaccinate, but "hesitancy to talk about ivermectin" and other early treatments. The caller cited the evidence about this drug, which "does no harm" and causes no risk to try it. The female caller completed her thought by asking him, "Are we doing anything with that, and if not, why not?"

As if to illustrate the caller's point, Pallister responded to her question about hesitancy to talk about ivermectin by ... refusing to talk about ivermectin! Like a programmed robot, Pallister blinked his eyes during her question, then proceeded to answer by discussing more about the vaccine! "We're pursuing domestic research that we hope can lead to better vaccine availability in the future, perhaps not during this wave, but when we need boosters in coming years," answered the Manitoban premier. He then quickly finished the discussion, put on his mask (even though he is vaccinated), and concluded the session.

This video embodies the criminal behavior of the political class in censoring lifesaving, cheap treatments like ivermectin. Even in vaccine-crazed Israel, they found in a small study of 30 patients that all of them recovered with the use of ivermectin, 29 of them within 3-5 days. In India, which was a hot spot until recently, much of the country began using ivermectin. Delhi saw a 99% decline in cases after beginning universal use of ivermectin. While cases were going down everywhere after reaching some level of immunity, a 99% reduction from April 24 to June 7 is remarkable and much steeper than anywhere else in the world following a big wave.

A similar dynamic played out in the state of Uttar Pradesh, which is now 98% off its peak of COVID cases in late April. India's overall reduction since its peak five weeks ago was 76%, more in line with what we saw in the U.S. and Europe, once the peak wave passed and a modicum of herd immunity kicked in.